Harbin Gloria Pharmaceuticals Co (SZSE:002437) Total Assets : ¥3,080 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Total Assets?

Harbin Gloria Pharmaceuticals Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,080 Mil.

During the past 12 months, Harbin Gloria Pharmaceuticals Co's average Total Assets Growth Rate was -11.80% per year. During the past 3 years, the average Total Assets Growth Rate was -12.40% per year. During the past 5 years, the average Total Assets Growth Rate was -20.50% per year. During the past 10 years, the average Total Assets Growth Rate was -4.30% per year.

During the past 13 years, Harbin Gloria Pharmaceuticals Co's highest 3-Year average Total Assets Growth Rate was 80.00%. The lowest was -27.00%. And the median was 37.90%.

Total Assets is connected with ROA %. Harbin Gloria Pharmaceuticals Co's annualized ROA % for the quarter that ended in Mar. 2024 was 6.71%. Total Assets is also linked to Revenue through Asset Turnover. Harbin Gloria Pharmaceuticals Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.19.

Harbin Gloria Pharmaceuticals Co Total Assets Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Total Assets Chart

Harbin Gloria Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

6,407.58

4,527.25

4,695.14

4,074.19

3,152.45

Harbin Gloria Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															3,948.40	3,617.62	3,559.33	3,152.45	3,079.87

Harbin Gloria Pharmaceuticals Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Harbin Gloria Pharmaceuticals Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1710.231	+	1442.219
	=	3,152

Harbin Gloria Pharmaceuticals Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	1860.412	+	1219.453
	=	3,080

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Total Assets Explanation

Total Assets is connected with ROA %.

Harbin Gloria Pharmaceuticals Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	209.132	/	( (3152.45	+	3079.865)	/ 2 )
	=	209.132	/	3116.1575
	=	6.71 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Harbin Gloria Pharmaceuticals Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	593.133	/	( (3152.45	+	3079.865)	/ 2 )
=	593.133	/	3116.1575
=	0.19

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Harbin Gloria Pharmaceuticals Co Total Assets Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025

Website

http://www.gloria.cc

Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Executives

Guo Yun Pei	Independent director
Wang Yu	Supervisors
Yang Hong Bing	Director
Diao Xiu Qiang	Directors, executives
Liu Yue Yin	Securities Affairs Representative
Guo Lei Feng	Directors, Directors, and Executives
Li Jun Ling	Director
Yang Hai Feng	Executives
Zhang Su Mei	Supervisors
Zhu Ji Man	Director

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines